Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
- September -
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
- 2012 -
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
September 2012 - 37 products
IP
CI
Lenzetto
PR
PR
k.A.
transdermales Spray: Estradiolum 1.53 mg
Gedeon Richter
(Schweiz) AG
B
FB
G
IP
CI
Lenzetto
3
PR
PR
k.A.
transdermales Spray: Estradiolum 1.53 mg
Gedeon Richter
(Schweiz) AG
B
FB
G
IP
Zoledronat Fresenius Onco 4
mg/5 ml
Durchstechflasche(n)
98.47
124.00
10 %
Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml
Fresenius Kabi
(Schweiz) AG
B / SL / SG
FB
G
IP
CI
Desloratadin Sandoz
10 Tablet(s)
2.32
4.30
10 %
Coated tablets: Desloratadinum 5 mg
Sandoz
Pharmaceuticals AG
D / SL / SG
FB
G
IP
CI
Desloratadin Sandoz
30 Tablet(s)
6.88
12.70
10 %
Coated tablets: Desloratadinum 5 mg
Sandoz
Pharmaceuticals AG
D / SL / SG
FB
G
IP
CI
Desloratadin Sandoz
50 Tablet(s)
11.27
20.80
10 %
Coated tablets: Desloratadinum 5 mg
Sandoz
Pharmaceuticals AG
●
D / SL / SG
FB
G
IP
V/S
Albunorm 5 %
100 ml
19.48
37.60
10 %
Infusion solution: Albuminum Humanum 50 g/l
Octapharma AG
B / SL
FB
G
IP
V/S
Albunorm 5 %
250 ml
46.00
66.45
10 %
Infusion solution: Albuminum Humanum 50 g/l
Octapharma AG
B / SL
FB
G
IP
V/S
Albunorm 5 %
500 ml
91.00
115.40
10 %
Infusion solution: Albuminum Humanum 50 g/l
Octapharma AG
B / SL
FB
G
IP
V/S
Albunorm 20 %
50 ml
36.00
55.55
10 %
Infusion solution: Albuminum Humanum 200 g/l
Octapharma AG
B / SL
FB
G
IP
V/S
Albunorm 20 %
100 ml
69.00
91.45
10 %
Infusion solution: Albuminum Humanum 200 g/l
Octapharma AG
B / SL
FB
G
IP
CI
Spasmex 20 mg
30
10.81
28.15
10 %
Coated tablets: Trospii Chloridum 20 mg
Zeller Medical AG
B / SL
FB
G
IP
CI
Spasmex 20 mg
100
33.26
52.60
10 %
Coated tablets: Trospii Chloridum 20 mg
Zeller Medical AG
B / SL
FB
G
L
IP
CI
Buccolam 2.5mg/0.5mL
4 syringe(s)
85.68
109.60
10 %
Lösung zur Anwendung in der Mundhöhle: Midazolamum 2.5mg / 0.5ml
Neuraxpharm
Switzerland AG
B / SL
FB
G
L
IP
CI
Buccolam 5mg/1mL
4 syringe(s)
85.68
109.60
10 %
Lösung zur Anwendung in der Mundhöhle: Midazolamum 5 mg/ml
Neuraxpharm
Switzerland AG
B / SL
FB
G
L
IP
CI
Buccolam 7.5mg/1.5mL
4 syringe(s)
85.68
109.60
10 %
Lösung zur Anwendung in der Mundhöhle: Midazolamum 7.5mg / 1.5ml
Neuraxpharm
Switzerland AG
B / SL
FB
G
L
IP
CI
Buccolam 10mg/2mL
4 syringe(s)
85.68
109.60
10 %
Lösung zur Anwendung in der Mundhöhle: Midazolamum 10mg / 2ml
Neuraxpharm
Switzerland AG
B / SL
FB
G
IP
V/S
Albunorm 5 %
10 x 100 ml
PR
PR
k.A.
Infusion solution: Albuminum Humanum 50 g/l
Octapharma AG
B
FB
G
IP
V/S
Albunorm 5 %
10 x 250 ml
PR
PR
k.A.
Infusion solution: Albuminum Humanum 50 g/l
Octapharma AG
B
FB
G
IP
V/S
Albunorm 20 %
10 x 50 ml
PR
PR
k.A.
Infusion solution: Albuminum Humanum 200 g/l
Octapharma AG
B
FB
G
IP
V/S
Albunorm 20 %
10 x 100 ml
PR
PR
k.A.
Infusion solution: Albuminum Humanum 200 g/l
Octapharma AG
B
FB
G
Ph
Carmol Bonbons pour la
gorge
75 g
PR
PR
k.A.
Pastilles: 4 Active Agents
VERFORA SA
E
FB
G
IP
CI
Cyproderm
21 Dragée(s)
PR
PR
k.A.
Dragées: 2 Active Agents
Dermapharm AG
B / LPPV
FB
G
IP
CI
Cyproderm
3 x 21 Dragée(s)
PR
PR
k.A.
Dragées: 2 Active Agents
Dermapharm AG
B / LPPV
FB
G
IP
CI
CM
Coop Vitality Cetirizin 10 mg
10
PR
PR
k.A.
Coated tablets: Cetirizini Dihydrochloridum 10 mg
Coop Vitality Health
Care GmbH
D
FB
G
IP
CI
CM
Coop Vitality Cetirizin 10 mg
10
PR
PR
k.A.
Coated tablets: Cetirizini Dihydrochloridum 10 mg
Coop Vitality Health
Care GmbH
D
FB
G
IP
CI
Spasmex 20 mg
50
PR
PR
k.A.
Coated tablets: Trospii Chloridum 20 mg
Zeller Medical AG
B
FB
G
IP
CI
Spasmex 20 mg
10 x 50
PR
PR
k.A.
Coated tablets: Trospii Chloridum 20 mg
Zeller Medical AG
B
FB
G
CI
H
Similasan Schlafstörungen
60 Tablet(s)
PR
PR
k.A.
Tablets: 4 Active Agents
Similasan AG
D
FB
G
IP
CI
Buccolam 2.5mg/0.5mL
2
PR
PR
k.A.
Lösung zur Anwendung in der Mundhöhle: Midazolamum 2.5mg / 0.5ml
Neuraxpharm
Switzerland AG
B
FB
G
IP
CI
Buccolam 5mg/1mL
2
PR
PR
k.A.
Lösung zur Anwendung in der Mundhöhle: Midazolamum 5 mg/ml
Neuraxpharm
Switzerland AG
B
FB
G
IP
CI
Buccolam 7.5mg/1.5mL
2
PR
PR
k.A.
Lösung zur Anwendung in der Mundhöhle: Midazolamum 7.5mg / 1.5ml
Neuraxpharm
Switzerland AG
B
FB
G
IP
CI
Buccolam 10mg/2mL
2
PR
PR
k.A.
Lösung zur Anwendung in der Mundhöhle: Midazolamum 10mg / 2ml
Neuraxpharm
Switzerland AG
B
FB
G
IP
CI
Lenzetto
Flasche(n) à 8.1 ml
17.68
36.80
k.A.
transdermales Spray: Estradiolum 1.53 mg
Gedeon Richter
(Schweiz) AG
B
FB
G
CI
Ph
BronchoVerde Hustenlöser
55 ml
PR
PR
k.A.
Sirup: Hederae Helicis Extractum Ethanolicum Siccum 8.712 mg/ml
Uriach Switzerland AG
D
FB
G
CI
Ph
BronchoVerde Hustenlöser
100 ml
PR
PR
k.A.
Sirup: Hederae Helicis Extractum Ethanolicum Siccum 8.712 mg/ml
Uriach Switzerland AG
D
FB
G
CI
Ph
BronchoVerde Hustenlöser
100 ml
PR
PR
k.A.
Sirup: Hederae Helicis Extractum Ethanolicum Siccum 8.712 mg/ml
Uriach Switzerland AG
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
